January 19: Short Course 1: Reference Safety Information January 20: Short Course 2: Pharmacovigilance and Risk Management Planning
Wednesday, January 20, 2021 10:00 AM–12:00 PM - Pharmacovigilance and Risk Management Planning Part 1
Thursday, January 21, 2021 10:00 AM–1:45 PM - Pharmacovigilance and Risk Management Planning Part 2
Friday, January 22, 2021 10:00 AM–1:45 PM - Pharmacovigilance and Risk Management Planning Part 3 January 25: Short Course 3: Introduction to Statistics in Pharmacovigilance January 26-28: Conference
DIA 2021 Exclusive
DIA is hosting a series of content previews around the United States counting down to the DIA 2021 Global Annual Meeting, and we're kicking off the series in conjunction with the DIA Pharmacovigilance and Risk Management Strategies Conference!* Register Today
Time to Save!
Enhance your experience and register for the full conference, and two short courses at the same time and receive $100 in savings. Purchase must happen at same time. Discount will be reflected on the last page of the cart.
Register Today
Upon completion of registration, participants will gain access to the following:
Live Event Access
Presentation Slides
Access to recorded sessions, on demand for 4 months post event
As global events continue to accelerate the shift to digital meeting formats, the ways in which we collaborate have also evolved. Here are three key reasons to consider attending a virtual DIA Specialty Event!
The Advantage of DIA Virtual Conferences
As global events continue to accelerate the shift to digital meeting formats, the ways in which we collaborate have also evolved.
Learn More
(Non-CE) Sponsored Roundtable Discussion
Covance: Assessing Safety and Managing the Risks of Vaccine Development at a ‘Pandemic Speed’ Vaccines for COVID19 are being developed across the world at speeds that have never been previously achieved. With such an extraordinary effort we are bound to encounter challenges from a postmarketing safety monitoring and vaccine safety communication perspective. The vaccine will have to be administered swiftly and effectively across diverse populations that requires robust pharmacovigilance and surveillance systems to be in place to handle the imminent surge in safety reports and supporting data, and to also account for effective vaccine safety communication. The success of this colossal undertaking will require significant investment and collaboration from stakeholders across the globe.
Click Here to learn more or reserve your spot!
(Non-CE) Sponsored Roundtable Discussion
The Next Generation of Pharmacovigilance The pharmacovigilance landscape is changing rapidly, setting the scene for the next generation of pharmacovigilance, shaped by converging forces from the healthcare, technology, regulatory, and societal domains. From advances in genomics, nanotechnology, and artificial intelligence to the exponential increase in the velocity and volume of data – the demands on PV Organizations in the future will be unprecedented, and all amidst mounting pressures from society for greater transparency.
Click Here to learn more or reserve your spot!